BYAM REBECCA (Chief Financial Officer) exercised options at HCW BIOLOGICS INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 10/23/2023ACC: 0001209191-23-053344
Officer· Chief Financial Officer
Since Jul 2021
0.00
Net shares
Net seller
$6.6K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
47.25K acquired · 47.25K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+47.25K
Price / share
$0.14
Trade value
$6.61K
% of position
8.2%
10/19/2023
573.95K→621.20K
Total
Net shares
+47.25K
Net value
$6.61K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/19/2023 | M · Option Exercise | +47.25K | $0.14 | $6.61K | 8.2% | 573.95K | 621.20K |
| Total | +47.25K | $6.61K | ||||||
Derivative Transactions1
Stock Option Grant (Right to Buy)
Direct
Converts to
Common Stock
47.25K shares
Shares
−47.25K
Strike price
0.14
Held after
0.00
Exercisable
—
10/19/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option Grant (Right to Buy) Direct | Common Stock47.25K shares | 10/19/2023 | M · Option Exercise | −47.25K | 0.14 | — | 0.00 |